Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure

Kentaro Kamiya1, Yukihito Sato2, Tetsuya Takahashi3

  • 1Department of Rehabilitation, School of Allied Health Sciences (K.K.), Kitasato University, Kanagawa, Japan.

Circulation. Heart Failure
|September 28, 2020
PubMed

Insights

Outpatient cardiac rehabilitation (CR) significantly improves survival and reduces rehospitalization for heart failure (HF) patients. These benefits were observed across diverse patient groups, including the elderly and frail.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Background:

  • Exercise-based cardiac rehabilitation (CR) is known to improve quality of life and exercise capacity in heart failure (HF) patients.
  • The efficacy of CR in specific HF populations, including the elderly, frail, and those with HF with preserved ejection fraction (HFpEF), requires further investigation.

Purpose of the Study:

  • To investigate the association between multidisciplinary outpatient CR participation and long-term survival and rehospitalization rates in a large cohort of HF patients.
  • To conduct subgroup analyses based on age, sex, comorbidities, frailty, and HFpEF to determine if CR benefits vary across these groups.

Main Methods:

  • A multicenter retrospective cohort study involving patients hospitalized for acute HF between 2007 and 2016 across 15 hospitals in Japan.
  • Propensity score matching was used to compare outcomes (composite of all-cause mortality and HF rehospitalization, all-cause mortality, HF rehospitalization) between CR participants and non-participants.

Main Results:

  • Out of 3277 patients, 862 (26%) participated in outpatient CR. After matching, 1592 patients (796 pairs) were analyzed.
  • CR participation was associated with a 23% reduced risk of the composite outcome (HR, 0.77; 95% CI, 0.65-0.92), a 33% reduction in all-cause mortality (HR, 0.67; 95% CI, 0.51-0.87), and a 18% reduction in HF rehospitalization (HR, 0.82; 95% CI, 0.67-0.99).
  • Numerically lower composite outcome rates were observed in patients with HFpEF and frail patients participating in CR.

Conclusions:

  • Outpatient CR participation demonstrates significant prognostic benefits for a broad spectrum of heart failure patients.
  • These benefits appear consistent across various patient demographics and clinical characteristics, including age, sex, comorbidities, frailty, and HFpEF.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
272
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
142
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
234
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
183
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
157